{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:08:38Z","timestamp":1789186118622,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.intimp.2020.106979","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T16:55:01Z","timestamp":1600880101000},"page":"106979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Activated coagulation is associated with the disease activity of axial spondyloarthritis"],"prefix":"10.1016","volume":"88","author":[{"given":"Yehao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianheng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinai","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingliang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Jie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10089","key":"10.1016\/j.intimp.2020.106979_b0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","article-title":"Axial spondyloarthritis","volume":"390","author":"Sieper","year":"2017","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.intimp.2020.106979_b0010","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/acr.21621","article-title":"Prevalence of axial spondylarthritis in the United States: estimates from a cross-sectional survey","volume":"64","author":"Reveille","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"10.1016\/j.intimp.2020.106979_b0015","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/acr.21804","article-title":"Assessment of spondyloarthritis International Society criteria for axial spondyloarthritis in chronic back pain patients with a high prevalence of HLA-B27","volume":"65","author":"Bakland","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1016\/j.intimp.2020.106979_b0020","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/annrheumdis-2013-204436","article-title":"Prevalence of spondyloarthritis in reference to HLA-B27 in the French population: results of the GAZEL cohort","volume":"74","author":"Costantino","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2020.106979_b0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jbspin.2007.04.011","article-title":"Cardiovascular disease in patients with spondyloarthropathies","volume":"75","author":"Vinsonneau","year":"2008","journal-title":"Joint Bone Spine"},{"issue":"2","key":"10.1016\/j.intimp.2020.106979_b0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/01.SMJ.0000153572.22346.E9","article-title":"Laboratory testing in the rheumatic diseases: a practical review","volume":"98","author":"Colglazier","year":"2005","journal-title":"South. Med. J."},{"issue":"4","key":"10.1016\/j.intimp.2020.106979_b0035","first-page":"980","article-title":"Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis","volume":"26","author":"Spoorenberg","year":"1999","journal-title":"J. Rheumatol."},{"issue":"17","key":"10.1016\/j.intimp.2020.106979_b0040","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.2174\/0929867043364603","article-title":"The hemostatic system","volume":"11","author":"Stassen","year":"2004","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2020.106979_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00281-011-0298-0","article-title":"Coagulation and inflammation\u2013close allies in health and disease","volume":"34","author":"Dahlback","year":"2012","journal-title":"Semin. Immunopathol."},{"issue":"2 Suppl","key":"10.1016\/j.intimp.2020.106979_b0050","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/CCM.0b013e3181c98d21","article-title":"Inflammation and coagulation","volume":"38","author":"Levi","year":"2010","journal-title":"Crit. Care Med."},{"issue":"2","key":"10.1016\/j.intimp.2020.106979_b0055","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/0961203318819137","article-title":"Evaluation of coagulation disorders by thromboelastography in children with systemic lupus erythematosus","volume":"28","author":"Li","year":"2019","journal-title":"Lupus."},{"issue":"6","key":"10.1016\/j.intimp.2020.106979_b0060","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/annrheumdis-2013-204767","article-title":"Thromboembolic and cardiovascular risk in rheumatoid arthritis: role of the haemostatic system","volume":"73","author":"van den Oever","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.intimp.2020.106979_b0065","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1055\/s-0035-1556590","article-title":"Hypercoagulability and platelet abnormalities in inflammatory bowel disease","volume":"41","author":"Senchenkova","year":"2015","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.intimp.2020.106979_b0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cca.2018.12.008","article-title":"Correlation between active disease and hypercoagulability state in patients with systemic lupus erythematosus","volume":"490","author":"Ferreira","year":"2019","journal-title":"Clin. Chim. Acta."},{"issue":"12","key":"10.1016\/j.intimp.2020.106979_b0075","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index","volume":"21","author":"Garrett","year":"1994","journal-title":"J. Rheumatol."},{"issue":"8","key":"10.1016\/j.intimp.2020.106979_b0080","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/rheumatology\/34.8.793","article-title":"Bath ankylosing spondylitis functional index","volume":"34","author":"Calin","year":"1995","journal-title":"Br J Rheumatol."},{"issue":"4","key":"10.1016\/j.intimp.2020.106979_b0085","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/ard.2007.074724","article-title":"Proposal of a linear definition of the bath ankylosing spondylitis metrology index (BASMI) and comparison with the 2-step and 10-step definitions","volume":"67","author":"van der Heijde","year":"2008","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.intimp.2020.106979_b0090","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood-2006-08-040956","article-title":"Human plasma fibrinogen is synthesized in the liver","volume":"109","author":"Tennent","year":"2007","journal-title":"Blood."},{"key":"10.1016\/j.intimp.2020.106979_b0095","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/978-3-319-49674-0_13","article-title":"Fibrin Formation, Structure and Properties","volume":"82","author":"Weisel","year":"2017","journal-title":"Subcell Biochem."},{"key":"10.1016\/j.intimp.2020.106979_b0100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0065-3233(05)70008-5","article-title":"Fibrinogen and fibrin","volume":"70","author":"Weisel","year":"2005","journal-title":"Adv. Protein Chem."},{"issue":"7","key":"10.1016\/j.intimp.2020.106979_b0105","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2217\/bmm-2017-0371","article-title":"Clinical significance of detecting HLA-DR, 14-3-3eta protein and d-dimer in the diagnosis of rheumatoid arthritis","volume":"12","author":"Tan","year":"2018","journal-title":"Biomark. Med."},{"issue":"13","key":"10.1016\/j.intimp.2020.106979_b0110","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa023153","article-title":"Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis","volume":"349","author":"Wells","year":"2003","journal-title":"N Engl. J. Med."},{"issue":"11","key":"10.1016\/j.intimp.2020.106979_b0115","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.amjmed.2009.03.032","article-title":"D-dimer testing in patients with suspected pulmonary embolism and impaired renal function","volume":"122","author":"Karami-Djurabi","year":"2009","journal-title":"Am. J. Med."},{"issue":"8","key":"10.1016\/j.intimp.2020.106979_b0120","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jamadermatol.2013.9944","article-title":"D-dimer levels as a marker of cutaneous disease activity: case reports of cutaneous polyarteritis nodosa and atypical recurrent urticaria","volume":"150","author":"Kirchhof","year":"2014","journal-title":"Jama Dermatol."},{"issue":"6","key":"10.1016\/j.intimp.2020.106979_b0125","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1007\/s10147-018-1320-5","article-title":"Prognostic and predictive value of plasma D-dimer levels in patients with small-cell lung cancer","volume":"23","author":"Zhang","year":"2018","journal-title":"Int. J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.intimp.2020.106979_b0130","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nrrheum.2012.184","article-title":"Coagulation and the fibrin network in rheumatic disease: a role beyond haemostasis","volume":"8","author":"Hoppe","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"issue":"3","key":"10.1016\/j.intimp.2020.106979_b0135","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11239-017-1528-7","article-title":"Venous thromboembolism: thrombosis, inflammation, and immunothrombosis for clinicians","volume":"44","author":"Vazquez-Garza","year":"2017","journal-title":"J. Thromb. Thrombolysis"},{"issue":"2","key":"10.1016\/j.intimp.2020.106979_b0140","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jaut.2008.07.002","article-title":"Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-alpha blockade","volume":"31","author":"Ingegnoli","year":"2008","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.intimp.2020.106979_b0145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/cei.13374","article-title":"Plasma levels of H- and L-ficolin are increased in axial spondyloarthritis: improvement of disease identification","volume":"199","author":"Troldborg","year":"2020","journal-title":"Clin. Exp. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2020.106979_b0150","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/rheumatology\/kez200","article-title":"From coagulation to inflammation: novel avenues for treating rheumatoid arthritis with activated protein C","volume":"58","author":"Boissier","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"22","key":"10.1016\/j.intimp.2020.106979_b0155","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.3390\/ijms20225552","article-title":"Wnt signaling and biological therapy in rheumatoid arthritis and spondyloarthritis","volume":"20","author":"Cici","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2020.106979_b0160","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00281-011-0290-8","article-title":"Fibrinogen as a key regulator of inflammation in disease","volume":"34","author":"Davalos","year":"2012","journal-title":"Semin. Immunopathol."},{"issue":"18","key":"10.1016\/j.intimp.2020.106979_b0165","doi-asserted-by":"crossref","first-page":"18127","DOI":"10.1074\/jbc.M310438200","article-title":"Tumor necrosis factor alpha activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor kappaB site","volume":"279","author":"Hou","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.intimp.2020.106979_b0170","doi-asserted-by":"crossref","first-page":"e44668","DOI":"10.1371\/journal.pone.0044668","article-title":"Early vascular alterations in SLE and RA patients\u2013a step towards understanding the associated cardiovascular risk","volume":"7","author":"Santos","year":"2012","journal-title":"Plos One."},{"key":"10.1016\/j.intimp.2020.106979_b0175","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3389\/fimmu.2019.00305","article-title":"Biomarkers for diagnosis of axial spondyloarthritis disease activity, prognosis, and prediction of response to therapy","volume":"10","author":"Maksymowych","year":"2019","journal-title":"Front Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2020.106979_b0180","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.autrev.2016.06.001","article-title":"Detection of novel diagnostic antibodies in ankylosing spondylitis: an overview","volume":"15","author":"Quaden","year":"2016","journal-title":"Autoimmun. Rev."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920324838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920324838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T22:41:25Z","timestamp":1744497685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920324838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":36,"alternative-id":["S1567576920324838"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106979","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activated coagulation is associated with the disease activity of axial spondyloarthritis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106979","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106979"}}